Most sold healthcare stocks in Q2 2026
Discover which Healthcare stocks institutional investors trimmed or exited the most over Q2 2026 versus the prior calendar quarter in our filings. Notable reductions at the top of this list include AMICUS THERAPEUTICS INC (FOLD), HOLOGIC INC (HOLX), CENTESSA PHARMACEUTICALS-ADR (CNTA), APELLIS PHARMACEUTICALS INC (APLS). These rankings aggregate SEC 13F filings from all institutional investors in our database.
Net share decreases
Top symbols by net quarter-over-quarter share change (decreases).
Most sold stocks
Net quarter-over-quarter share reductions across all institutional filers.
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| FOLD | AMICUS THERAPEUTICS INC | -324,056,762 | -$4.5B | 0 | 0 | 1 | 291 | 2 |
| HOLX | HOLOGIC INC | -210,825,030 | -$15.3B | 0 | 0 | 2 | 684 | 6 |
| CNTA | CENTESSA PHARMACEUTICALS-ADR | -148,157,171 | -$5.9B | 0 | 0 | 0 | 159 | 0 |
| APLS | APELLIS PHARMACEUTICALS INC | -137,871,069 | -$5.4B | 0 | 0 | 1 | 314 | 3 |
| MYGN | MYRIAD GENETICS INC | -122,308,004 | -$1.3M | 44 | 69 | 55 | 57 | 187 |
| TERN | TERNS PHARMACEUTICALS INC | -121,701,864 | -$6.1B | 0 | 0 | 0 | 308 | 2 |
| SGMO | SANGAMO THERAPEUTICS INC | -104,799,198 | -$26.0M | 3 | 1 | 0 | 107 | 6 |
| DAWN | DAY ONE BIOPHARMACEUTICALS I | -83,420,779 | -$1.7B | 0 | 0 | 1 | 202 | 1 |
| KALV | KALVISTA PHARMACEUTICALS INC | -69,229,726 | -$1.4B | 1 | 0 | 0 | 181 | 1 |
| IMUX | IMMUNIC INC | -57,927,369 | -$69.3M | 0 | 0 | 0 | 73 | 0 |
| ACLX | ARCELLX INC | -55,745,918 | -$5.9B | 0 | 1 | 0 | 232 | 2 |
| SLNO | SOLENO THERAPEUTICS INC | -55,206,861 | -$1.8B | 0 | 0 | 0 | 222 | 0 |
| MASI | MASIMO CORP | -53,367,977 | -$9.2B | 0 | 0 | 2 | 433 | 4 |
| ASND | ASCENDIS PHARMA A/S - ADR | -52,749,119 | -$11.9B | 2 | 4 | 0 | 253 | 10 |
| EHAB | ENHABIT INC | -48,570,910 | -$665.7M | 0 | 1 | 0 | 170 | 1 |
| ENGN | ENGENE HOLDINGS INC | -44,288,950 | -$359.9M | 1 | 1 | 0 | 54 | 5 |
| RCEL | AVITA MEDICAL INC | -41,345,929 | -$50.9M | 22 | 23 | 19 | 27 | 71 |
| GSK | GSK PLC-SPON ADR | -29,850,678 | -$2.2B | 107 | 352 | 316 | 131 | 983 |
| SCYX | SCYNEXIS INC | -29,828,885 | -$26.6M | 0 | 0 | 0 | 44 | 0 |
| IVVD | INVIVYD INC | -27,725,516 | -$119.6M | 35 | 37 | 26 | 49 | 124 |
| HRTX | HERON THERAPEUTICS INC | -25,610,246 | -$69.2M | 21 | 56 | 38 | 29 | 156 |
| STIM | NEURONETICS INC | -22,957,804 | -$36.1M | 18 | 27 | 22 | 32 | 83 |
| VNRX | VOLITIONRX LTD | -22,375,280 | -$4.5M | 0 | 0 | 0 | 31 | 0 |
| CUE | CUE BIOPHARMA INC | -21,387,216 | -$4.9M | 0 | 0 | 0 | 52 | 1 |
| SEM | SELECT MEDICAL HOLDINGS CORP | -19,854,307 | -$206.8M | 45 | 57 | 78 | 91 | 226 |
| MREO | MEREO BIOPHARMA GROUP PL-ADR | -18,745,204 | -$6.8M | 17 | 12 | 12 | 18 | 60 |
| BSX | BOSTON SCIENTIFIC CORP | -18,614,811 | -$25.4B | 145 | 545 | 581 | 391 | 1394 |
| ATYR | ATYR PHARMA INC | -17,594,109 | -$21.3M | 18 | 26 | 29 | 40 | 87 |
| SNY | SANOFI-ADR | -16,427,855 | -$1.7B | 88 | 201 | 276 | 139 | 674 |
| SGRY | SURGERY PARTNERS INC | -15,460,862 | $439.0M | 34 | 69 | 46 | 39 | 176 |
| CNTX | CONTEXT THERAPEUTICS INC | -15,344,916 | -$160.8M | 38 | 17 | 12 | 18 | 78 |
| BBIO | BRIDGEBIO PHARMA INC | -15,280,398 | -$949.7M | 79 | 162 | 159 | 84 | 445 |
| BCAB | BIOATLA INC | -15,271,228 | -$1.8M | 0 | 0 | 1 | 32 | 1 |
| GERN | GERON CORP | -15,109,856 | -$121.9M | 36 | 93 | 55 | 41 | 247 |
| QNCX | QUINCE THERAPEUTICS INC | -14,392,056 | -$2.0M | 0 | 0 | 0 | 39 | 0 |
| APGE | APOGEE THERAPEUTICS INC | -14,276,935 | $2.7B | 107 | 81 | 62 | 57 | 271 |
| NVS | NOVARTIS AG-SPONSORED ADR | -13,746,062 | -$1.5B | 129 | 500 | 535 | 170 | 1529 |
| ABCL | ABCELLERA BIOLOGICS INC | -13,433,897 | $415.9M | 40 | 35 | 51 | 29 | 146 |
| CMPX | COMPASS THERAPEUTICS INC | -13,391,025 | -$568.5M | 63 | 81 | 38 | 58 | 203 |
| ZTS | ZOETIS INC | -13,081,903 | -$19.0B | 164 | 469 | 555 | 392 | 1337 |
| PCVX | VAXCYTE INC | -12,227,599 | -$754.1M | 46 | 123 | 94 | 68 | 309 |
| EMBC | EMBECTA CORP | -11,882,748 | -$357.6M | 59 | 75 | 67 | 93 | 297 |
| NMTC | NEUROONE MEDICAL TECHNOLOGIE | -11,710,397 | -$9.0M | 0 | 0 | 2 | 28 | 2 |
| QSI | QUANTUM-SI INC | -11,094,398 | -$26.8M | 27 | 32 | 54 | 46 | 135 |
| RVTY | REVVITY INC | -9,508,701 | $1.8B | 102 | 180 | 155 | 83 | 512 |
| PSTV | PLUS THERAPEUTICS INC | -9,136,481 | -$1.5M | 0 | 0 | 0 | 24 | 0 |
| DYN | DYNE THERAPEUTICS INC | -8,921,653 | $384.3M | 48 | 84 | 71 | 39 | 234 |
| OLMA | OLEMA PHARMACEUTICALS INC | -8,608,598 | -$340.9M | 23 | 68 | 58 | 43 | 174 |
| QTRX | QUANTERIX CORP | -8,208,031 | -$7.8M | 37 | 41 | 28 | 37 | 125 |
| FEMY | FEMASYS INC | -7,984,040 | -$3.3M | 0 | 0 | 1 | 32 | 2 |